Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model

Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model

Alzheimer’s disease (AD) is the most common neurodegenerative disease. Growing evidence suggests an important role for gut dysbiosis and gut microbiota-host interactions in aging and neurodegeneration. Our previous works have demonstrated that supplementation with the nicotinamide adenine dinucleoti...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Xixia Chu, Yujun Hou, Qiong Meng, Deborah L. Croteau, Yong Wei, Supriyo De, Kevin G. Becker, Vilhelm A. Bohr
Format: Artikel
Sprache:English
Veröffentlicht: Frontiers Media S.A. 2022-09-01
Schriftenreihe:Frontiers in Aging Neuroscience
Schlagworte:
Alzheimer’s disease
nicotinamide riboside
gut microbiome
APP/PS1 transgenic mice
neuroinflammation
aging
Online Zugang:https://www.frontiersin.org/articles/10.3389/fnagi.2022.993615/full

Online

https://www.frontiersin.org/articles/10.3389/fnagi.2022.993615/full

Ähnliche Einträge